GB0104259D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number: GB0104259D0
Authority: GB; United Kingdom
Prior art keywords: novel compounds; novel; compounds
Prior art date: 2001-02-21
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Ceased

Application number

GBGB0104259.7A

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

GlaxoSmithKline Biologicals SA

Corixa Corp

Original Assignee

SmithKline Beecham Biologicals SA

Corixa Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-02-21

Filing date

2001-02-21

Publication date

2001-04-11

2001-02-21 Application filed by SmithKline Beecham Biologicals SA, Corixa Corp filed Critical SmithKline Beecham Biologicals SA

2001-02-21 Priority to GBGB0104259.7A priority Critical patent/GB0104259D0/en

2001-04-11 Publication of GB0104259D0 publication Critical patent/GB0104259D0/en

2002-02-15 Priority to AU2002249221A priority patent/AU2002249221A1/en

2002-02-15 Priority to PCT/EP2002/001649 priority patent/WO2002066506A2/en

Status Ceased legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Biophysics (AREA)
Medicinal Chemistry (AREA)
Zoology (AREA)
Biochemistry (AREA)
Toxicology (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Gastroenterology & Hepatology (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Peptides Or Proteins (AREA)

GBGB0104259.7A 2001-02-21 2001-02-21 Novel compounds Ceased GB0104259D0 (en)

Priority Applications (3)

Application Number	Priority Date	Filing Date	Title
GBGB0104259.7A GB0104259D0 (en)	2001-02-21	2001-02-21	Novel compounds
AU2002249221A AU2002249221A1 (en)	2001-02-21	2002-02-15	Use of casb7439 (ash2) in the immunotherapy of breast cancer
PCT/EP2002/001649 WO2002066506A2 (en)	2001-02-21	2002-02-15	Use of casb7439 (ash2) in the immunotherapy of breast cancer

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB0104259.7A GB0104259D0 (en)	2001-02-21	2001-02-21	Novel compounds

Publications (1)

Publication Number	Publication Date
GB0104259D0 true GB0104259D0 (en)	2001-04-11

Family

ID=9909202

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GBGB0104259.7A Ceased GB0104259D0 (en)	2001-02-21	2001-02-21	Novel compounds

Country Status (3)

Country	Link
AU (1)	AU2002249221A1 (en)
GB (1)	GB0104259D0 (en)
WO (1)	WO2002066506A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0111974D0 (en) *	2001-05-16	2001-07-04	Glaxosmithkline Biolog Sa	Novel Compounds
SG176220A1 (en) *	2009-05-27	2011-12-29	Glaxosmithkline Biolog Sa	Casb7439 constructs
EP2701686A4 (en)	2011-04-28	2014-11-05	Stc Unm	Porous nanoparticle-supported lipid bilayers (protocells) for targeted delivery and methods of using same
GB201520592D0 (en) *	2015-11-23	2016-01-06	Immunocore Ltd & Adaptimmune Ltd	Peptides
WO2017120504A1 (en)	2016-01-08	2017-07-13	Durfee Paul N	Osteotropic nanoparticles for prevention or treatment of bone metastases
WO2018160865A1 (en)	2017-03-01	2018-09-07	Charles Jeffrey Brinker	Active targeting of cells by monosized protocells
WO2020068798A1 (en)	2018-09-24	2020-04-02	Guo Jimin	Living mammalian cells modified with functional modular nanoparticles
WO2020176716A1 (en)	2019-02-28	2020-09-03	Brinker C Jeffrey	Modular metal–organic polyhedra superassembly compositions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2001002828A2 (en) *	1999-07-07	2001-01-11	Tularik Inc.	Diagnosis of cancer by detecting ash2 polypeptides or polynucleotides

2001
- 2001-02-21 GB GBGB0104259.7A patent/GB0104259D0/en not_active Ceased
2002
- 2002-02-15 AU AU2002249221A patent/AU2002249221A1/en not_active Abandoned
- 2002-02-15 WO PCT/EP2002/001649 patent/WO2002066506A2/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
WO2002066506A3 (en)	2002-12-19
WO2002066506A2 (en)	2002-08-29
AU2002249221A1 (en)	2002-09-04

Publication	Publication Date	Title
GB0105895D0 (en)	2001-04-25	Novel compounds
AU2002359165A8 (en)	2003-06-30	Novel compounds
GB0106586D0 (en)	2001-05-09	Novel compounds
GB0104259D0 (en)	2001-04-11	Novel compounds
GB0103866D0 (en)	2001-04-04	Novel compounds
GB0102470D0 (en)	2001-03-14	Novel compounds
GB0102713D0 (en)	2001-03-21	Novel compounds
GB0111974D0 (en)	2001-07-04	Novel Compounds
GB0106157D0 (en)	2001-05-02	Novel compounds
GB0105095D0 (en)	2001-04-18	Novel compounds
GB0107906D0 (en)	2001-05-23	Novel compounds
GB0107659D0 (en)	2001-05-16	Novel compounds
GB0107632D0 (en)	2001-05-16	Novel compounds
GB0107631D0 (en)	2001-05-16	Novel compounds
GB0107626D0 (en)	2001-05-16	Novel compounds
GB0107391D0 (en)	2001-05-16	Novel compounds
GB0107389D0 (en)	2001-05-16	Novel compounds
GB0107388D0 (en)	2001-05-16	Novel compounds
GB0107116D0 (en)	2001-05-09	Novel compounds
GB0106613D0 (en)	2001-05-09	Novel compounds
GB0106584D0 (en)	2001-05-09	Novel compounds
GB0106451D0 (en)	2001-05-02	Novel compounds
GB0106447D0 (en)	2001-05-02	Novel compounds
GB0106158D0 (en)	2001-05-02	Novel Compounds
GB0111052D0 (en)	2001-06-27	Novel compounds

Legal Events

Date	Code	Title	Description
2002-05-22	AT	Applications terminated before publication under section 16(1)